Skip to main navigation Skip to search Skip to main content

Two-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.

Åsa Wallin, Carina Wattmo, Annacarin Björkman, Sture Eriksson, Niels Andreasen, Lennart Minthon

Research output: Contribution to conferencePoster

235 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Two-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.'. Together they form a unique fingerprint.
Sort by

Neuroscience

Psychology